Echo Street Capital Management’s Blueprint Medicines BPMC Stock Holding History

Echo Street Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-9,417	Closed	-$473K	–	68
2023 Q3	$473K	Buy	9,417 +3,443	+58%	+$184K	﹤0.01%	279
2023 Q2	$378K	Buy	+5,974	New	+$325K	﹤0.01%	341
2022 Q4	–	Sell	-4,849	Closed	-$320K	–	507
2022 Q3	$320K	Buy	+4,849	New	+$311K	﹤0.01%	386
2021 Q4	–	Sell	-6,403	Closed	-$658K	–	630
2021 Q3	$658K	Buy	6,403 +2,946	+85%	+$274K	﹤0.01%	347
2021 Q2	$304K	Sell	3,457 -3,761	-52%	-$345K	﹤0.01%	485
2021 Q1	$702K	Buy	+7,218	New	+$721K	0.01%	232
2020 Q3	–	Sell	-12,678	Closed	-$989K	–	146
2020 Q2	$989K	Buy	+12,678	New	+$857K	0.01%	265

Other funds holding BPMC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Echo Street Capital Management's BPMC Position: Q4 2023 in Review

Echo Street Capital Management sold out of Blueprint Medicines (BPMC) in Q4 2023, closing a stake of 9,417 shares — an estimated $473K sold.

Echo Street Capital Management first reported a position in BPMC in Q2 2020 and held it in 7 quarters. The position peaked at $989K in Q2 2020. 259 funds tracked by Wall St. Rank hold BPMC as of Q4 2023.

Echo Street Capital Management reported no remaining Blueprint Medicines position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 9,417 Blueprint Medicines shares in Q4 2023, an estimated $473K.
Echo Street Capital Management first reported a position in Blueprint Medicines in Q2 2020 and held it in 7 quarters.
Echo Street Capital Management's Blueprint Medicines position peaked at $989K in Q2 2020.
259 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.